Abstract
Ameloblastic carcinoma is a rare lesion of odontogenic origin. It is defined as a malignant epithelial odontogenic tumor that histologically has retained the features of ameloblastic differentiation and also exhibits cytologic features of malignancy, like atypia and mitotic activity. Although this lesion represents a separate entity, differentiating it from ameloblastoma has been often challenging to pathologists. In this case study reporting a case of ameloblastic carcinoma, we have attempted to verify the previous findings on the use of Argyrophilic nucleolar organizing regions (AgNORs) and immunohistochemical staining for the alpha-smooth muscle actin (alpha-SMA) in differentiating ameloblastic carcinoma from ameloblastoma. It was observed that AgNORs was found to be almost twice in ameloblastic carcinoma as it was in ameloblastoma. A difference between the two lesions in the pattern of expression of alpha-SMA was also observed, with alpha-SMA being expressed in the odontogenic epithelium and the stroma of ameloblastic carcinoma whereas, in the case of ameloblastoma, it was found only in the stromal part. These findings suggest that AgNORs and alpha-SMA expression may be used as adjuncts to the routine histopathologic examination to differentiate ameloblastic carcinoma and ameloblastoma.
References
Angiero F, Borloni R, Macchi M, et al. Ameloblastic carcinoma of the maxillary sinus. Anticancer Res. 2008;28:3847–54.
Kruse AL, Zwahlen RA, Grätz KW. New classification of maxillary ameloblastic carcinoma based on an evidence-based literature review over the last 60 years. Head Neck Oncol. 2009;12:31.
Sciubba J. Odontogenic tumours. In: Barnes L, Eveson J, Reichart P, Sidransky D, editors. World Health Organization classification of tumours, pathology and genetics of head and neck tumours. Lyon, France: IARC Press; 2005. p. 287–93.
Rajendran R. Cysts and tumors of odontogenic origin. In: Rajendran R, Sivapathasundharan B, editors. Shafer’s textbook of oral pathology. 5th ed. New Delhi, India: Elsevier; 2006. p. 381–6.
Martins C, Carvalho YR, do Carmo MA. Argyrophilic nucleolar organizer regions (AgNORs) in odontogenic myxoma (OM) and ameloblastic fibroma (AF). J Oral Pathol Med. 2001;30:489–93.
Afolabi OC, Odukoya O, Arole G, et al. Evaluation of nucleolar organizer regions in tumors of the jaw bones. Niger Post Grad Med J. 2001;8:7–11.
Coleman HG, Altini M, Groeneveld HT. Nucleolar organizer regions (AgNORs) in odontogenic cysts and ameloblastomas. J Oral Pathol Med. 1996;25:436–40.
Lau S, Tideman H. Ameloblastic carcinoma of the jaws. A report of two cases. Oral Surgery Oral Med Oral Pathol Oral Radiol Endod. 1998;85:78–81.
Nakano K, Siar CH, Tsujigiwa H, et al. Notch signaling in benign and malignant ameloblastic neoplasms. Eur J Med Res. 2008;27:476–80.
Bologna-Molina R, Mosqueda-Taylor A, Lopez-Corella E, et al. Comparative expression of syndecan-1 and Ki-67 in peripheral and desmoplastic ameloblastomas and ameloblastic carcinoma. Pathol Int. 2009;59:229–33.
Bello IO, Alanen K, Slootweg PJ, et al. Alpha-smooth muscle actin within epithelial islands is predictive of ameloblastic carcinoma. Oral Oncol. 2009;45:760–5.
Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. Molecular biology of the cell. New York, USA: Garland Publishing Inc; 1983.
NORs: a new method for pathologists. Lancet. 1987;1:1413–1414.
Elangovan T, Mani NJ, Malathi N. Argyrophilic nucleolar organizer regions in inflammatory, premalignant, and malignant oral lesions: a quantitative and qualitative assessment. Indian J Dent Res. 2008;19:141–6.
De Wever O, Demetter P, Mareel M, et al. Stromal myofibroblasts are drivers of invasive cancer growth Int. J Cancer. 2008;123:2229–38.
Desmouliere A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myofibroblasts. Wound Repair Regen. 2005;13:7–12.
Crocker J, Nar P. Nuclear organizing regions in lymphomas. J Pathol. 1987;151:111–8.
De Wever O, Mareel M. Role of Myofibroblasts at the Invasion Front. Biol Chem. 2002;383:55–67.
Powell DW, Adegboyega PA, Di Mari JF, et al. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol. 2005;289:G2–7.
Kellermann MG, Sobral LM, da Silva SD, et al. Myofibroblasts in the stroma of oral squamous cell carcinoma are associated with poor prognosis. Histopathology. 2007;51:849–53.
Vered M, Shohat I, Buchner A, et al. Myofibroblasts in stroma of odontogenic cysts and tumors can contribute to variations in the biological behavior of lesions. Oral Oncol. 2005;41:1028–33.
Irazusta SP, Vassallo J, Magna LA. The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa. Pathol Res Pract. 1998;194:33–9.
Yue L, Iwai M, Furuta I. Evaluation of Argyrophilic nucleolar organizer regions in tongue squamous cell carcinomas. Oral Oncol. 1999;35:70–6.
Derenzini M. The AgNORs. Micron. 2000;31:117–20.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kamath, K.P., Vidya, M., Shetty, N. et al. Nucleolar Organizing Regions and α-Smooth Muscle Actin Expression in a Case of Ameloblastic Carcinoma. Head and Neck Pathol 4, 157–162 (2010). https://doi.org/10.1007/s12105-010-0173-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12105-010-0173-7